Page last updated: 2024-08-24

n-acetylmannosamine and Diabetic Glomerulosclerosis

n-acetylmannosamine has been researched along with Diabetic Glomerulosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gao, Y; Jiang, H; Ma, Y; Xie, D1
Chen, H; Guo, K; Lu, J; Ma, Y; Pan, P; Wu, M1

Other Studies

2 other study(ies) available for n-acetylmannosamine and Diabetic Glomerulosclerosis

ArticleYear
ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    International immunopharmacology, 2022, Volume: 107

    Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Female; Hexosamines; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Podocytes; Pyroptosis; Reactive Oxygen Species; Signal Transduction; Streptozocin

2022
Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
    Molecular and cellular endocrinology, 2020, 04-05, Volume: 505

    Topics: Actin Cytoskeleton; Angiopoietin-Like Protein 4; Animals; Apoptosis; Cell Line; Cell Line, Transformed; Diabetic Nephropathies; Focal Adhesion Protein-Tyrosine Kinases; Glucose; Hexosamines; Humans; Hyperglycemia; Integrin beta1; Male; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Podocytes; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation

2020